We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MIV to Acquire Sahajanand, Form Stent Company
MIV to Acquire Sahajanand, Form Stent Company
March 18, 2005
MIV Therapeutics (MIVT) has executed a letter of intent to acquire Sahajanand Medical Technologies (SMT) in order to form a drug-eluting stent company that would use MIVT’s next generation line of advanced biocompatible coatings with SMT’s stents, the companies said last week.